Evaluate Diagnostics

Evaluate Diagnostics is a biotechnology company. The company will launch a new system on the market for capturing extracellular vesicles (EVs), including exosomes, which have been difficult to capture in the medical field so far. New diagnostic assays derived from this technology will help select and identify disease biomarkers, enabling the detection of tumors and a variety of other diseases earlier than ever before.